Growth Metrics

Immuron (IMRN) Non Operating Income (2018 - 2023)

Immuron's quarterly Non Operating Income came in at $149501.0 in Q4 2023, up 201.59% year-on-year from $49571.0 in Q4 2022, and up 201.59% quarter-over-quarter from $49571.0 in Q4 2022.

Immuron has reported Non Operating Income for 6 years, with the latest figure at $149501.0 in Q4 2023.

  • For the quarter ending Q4 2023, Non Operating Income rose 201.59% year-over-year to $149501.0; the trailing twelve-month figure through Dec 2023 stood at $199121.8 (up 301.46% YoY), and the FY2025 full-year result was $83324.2, down 60.32% from the prior year.
  • Non Operating Income for Q4 2023 stood at $149501.0, up from $49571.0 in the prior quarter.
  • The five-year high for Non Operating Income was $149501.0 in Q4 2023, with the low at -$20.87 in Q4 2019.
  • Average Non Operating Income over 5 years is $39820.2, with a median of $65.87 recorded in 2021.
  • Year-over-year, Non Operating Income sank 153.51% in 2019 and surged 75154.62% in 2022.
  • Tracing IMRN's Non Operating Income over 5 years: stood at -$20.87 in 2019, then rose by 22.81% to -$16.11 in 2020, then surged by 508.88% to $65.87 in 2021, then surged by 75154.62% to $49571.0 in 2022, then surged by 201.59% to $149501.0 in 2023.
  • The last three Non Operating Income figures came in at $149501.0 (Q4 2023), $49571.0 (Q4 2022), and $65.87 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 444,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -46.98 Mn
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 149,501.00
Dec 31, 2022 49,571.00
Dec 31, 2021 65.87
Dec 31, 2020 -16.11
Dec 31, 2019 -20.87
Dec 31, 2018 39.00